| 0 |
CHEMICAL BURN OF GENITALIA |
29 |
0.2377 |
| 1 |
VULVOVAGINAL SWELLING |
295 |
0.1614 |
| 2 |
VULVOVAGINAL EXFOLIATION |
8 |
0.1538 |
| 3 |
BLOOD GLUCAGON ABNORMAL |
1 |
0.1250 |
| 4 |
VULVOVAGINAL BURNING SENSATION |
526 |
0.0861 |
| 5 |
ADMINISTRATION SITE PARAESTHESIA |
1 |
0.0667 |
| 6 |
VULVOVAGINAL ERYTHEMA |
52 |
0.0622 |
| 7 |
VAGINAL EXFOLIATION |
3 |
0.0577 |
| 8 |
INFLUENZA A VIRUS TEST |
1 |
0.0556 |
| 9 |
VULVOVAGINAL HYPOAESTHESIA |
1 |
0.0500 |
| 10 |
VULVAL ERYTHEMA |
1 |
0.0476 |
| 11 |
VULVOVAGINAL PAIN |
229 |
0.0475 |
| 12 |
VULVOVAGINAL ULCERATION |
2 |
0.0408 |
| 13 |
VULVOVAGINAL PRURITUS |
197 |
0.0389 |
| 14 |
VULVOVAGINAL DISCOMFORT |
161 |
0.0364 |
| 15 |
VAGINAL MUCOSAL BLISTERING |
8 |
0.0356 |
| 16 |
VULVOVAGINAL INFLAMMATION |
15 |
0.0325 |
| 17 |
TISSUE IRRITATION |
1 |
0.0303 |
| 18 |
GENITAL PARAESTHESIA |
8 |
0.0276 |
| 19 |
HAEMORRHAGIC URTICARIA |
1 |
0.0250 |
| 20 |
VAGINAL MYCOSIS |
5 |
0.0215 |
| 21 |
VULVOVAGINAL RASH |
9 |
0.0204 |
| 22 |
VAGINITIS |
1 |
0.0204 |
| 23 |
GASTROINTESTINAL TELANGIECTASIA |
1 |
0.0196 |
| 24 |
GENITAL BLISTER |
5 |
0.0181 |
| 25 |
SECOND DEGREE CHEMICAL BURN OF SKIN |
1 |
0.0167 |
| 26 |
LABIA ENLARGED |
1 |
0.0159 |
| 27 |
VULVOVAGINAL INJURY |
9 |
0.0158 |
| 28 |
GENITAL DISCOLOURATION |
1 |
0.0147 |
| 29 |
VAGINAL EROSION |
2 |
0.0128 |
| 30 |
REDUCED BLADDER CAPACITY |
1 |
0.0112 |
| 31 |
VAGINAL SWELLING |
4 |
0.0112 |
| 32 |
VAGINAL INFLAMMATION |
2 |
0.0090 |
| 33 |
CHEMICAL BURN |
10 |
0.0087 |
| 34 |
VAGINAL ODOUR |
10 |
0.0079 |
| 35 |
GENITAL INJURY |
1 |
0.0075 |
| 36 |
VAGINAL CONTRACEPTIVE DEVICE EXPELLED |
1 |
0.0071 |
| 37 |
ENLARGED CLITORIS |
1 |
0.0061 |
| 38 |
VAGINAL DISCHARGE |
59 |
0.0058 |
| 39 |
LUPUS VULGARIS |
6 |
0.0048 |
| 40 |
VAGINAL LACERATION |
1 |
0.0046 |
| 41 |
THERAPEUTIC PRODUCT CROSS-REACTIVITY |
4 |
0.0045 |
| 42 |
ERYTHEMA INFECTIOSUM |
1 |
0.0039 |
| 43 |
BACTERIAL VULVOVAGINITIS |
1 |
0.0035 |
| 44 |
VULVOVAGINITIS |
1 |
0.0034 |
| 45 |
OEDEMA GENITAL |
2 |
0.0031 |
| 46 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY |
2 |
0.0030 |
| 47 |
RETINITIS |
5 |
0.0029 |
| 48 |
APPLICATION SITE PUSTULES |
1 |
0.0027 |
| 49 |
SKIN ULCER HAEMORRHAGE |
1 |
0.0026 |
| 50 |
VULVAL OEDEMA |
1 |
0.0025 |
| 51 |
CHEMICAL INJURY |
2 |
0.0024 |
| 52 |
VAGINAL ULCERATION |
1 |
0.0024 |
| 53 |
PARVOVIRUS B19 INFECTION |
2 |
0.0022 |
| 54 |
SKIN INDENTATION |
1 |
0.0021 |
| 55 |
VULVOVAGINAL DRYNESS |
6 |
0.0019 |
| 56 |
SERONEGATIVE ARTHRITIS |
2 |
0.0017 |
| 57 |
HAEMORRHAGIC OVARIAN CYST |
1 |
0.0017 |
| 58 |
BONE EROSION |
6 |
0.0017 |
| 59 |
LYMPHATIC DISORDER |
1 |
0.0017 |
| 60 |
APPLICATION SITE WARMTH |
2 |
0.0016 |
| 61 |
HYPERCHOLESTEROLAEMIA |
15 |
0.0016 |
| 62 |
VULVAL DISORDER |
1 |
0.0015 |
| 63 |
HELICOBACTER INFECTION |
15 |
0.0015 |
| 64 |
BRAIN CONTUSION |
1 |
0.0014 |
| 65 |
GENITAL PAIN |
2 |
0.0014 |
| 66 |
MEDICAL DEVICE DISCOMFORT |
4 |
0.0013 |
| 67 |
GENITAL ULCERATION |
1 |
0.0013 |
| 68 |
VAGINAL HAEMORRHAGE |
54 |
0.0012 |
| 69 |
CRANIOSYNOSTOSIS |
1 |
0.0012 |
| 70 |
CLEFT LIP |
1 |
0.0011 |
| 71 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
5 |
0.0011 |
| 72 |
TRAUMATIC INTRACRANIAL HAEMORRHAGE |
1 |
0.0011 |
| 73 |
DEEP VEIN THROMBOSIS POSTOPERATIVE |
2 |
0.0010 |
| 74 |
FOREIGN BODY |
4 |
0.0010 |
| 75 |
STOMA COMPLICATION |
1 |
0.0010 |
| 76 |
GENITAL HYPOAESTHESIA |
1 |
0.0010 |
| 77 |
ADJUSTMENT DISORDER WITH DEPRESSED MOOD |
2 |
0.0010 |
| 78 |
APPLICATION SITE PAPULES |
1 |
0.0009 |
| 79 |
ALLERGY TO ANIMAL |
1 |
0.0009 |
| 80 |
DISLOCATION OF VERTEBRA |
2 |
0.0009 |
| 81 |
APPLICATION SITE SWELLING |
4 |
0.0008 |
| 82 |
CONDITION AGGRAVATED |
226 |
0.0007 |
| 83 |
UNDERDOSE |
54 |
0.0007 |
| 84 |
APPLICATION SITE HAEMORRHAGE |
2 |
0.0007 |
| 85 |
MAST CELL ACTIVATION SYNDROME |
1 |
0.0007 |
| 86 |
DRUG EFFECT LESS THAN EXPECTED |
10 |
0.0007 |
| 87 |
LUPUS-LIKE SYNDROME |
6 |
0.0007 |
| 88 |
EXOSTOSIS |
6 |
0.0007 |
| 89 |
RUBBER SENSITIVITY |
1 |
0.0007 |
| 90 |
BACTERIAL VAGINOSIS |
1 |
0.0006 |
| 91 |
VAGINAL INFECTION |
3 |
0.0006 |
| 92 |
EXPIRED PRODUCT ADMINISTERED |
21 |
0.0006 |
| 93 |
VIRAL UPPER RESPIRATORY TRACT INFECTION |
3 |
0.0006 |
| 94 |
SWOLLEN JOINT COUNT INCREASED |
2 |
0.0006 |
| 95 |
FIBROMYALGIA |
15 |
0.0006 |
| 96 |
DERMATITIS CONTACT |
7 |
0.0006 |
| 97 |
POLYMENORRHOEA |
2 |
0.0006 |
| 98 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 99 |
BURNS SECOND DEGREE |
1 |
0.0006 |
| 100 |
JOINT DISLOCATION |
6 |
0.0006 |
| 101 |
RED BLOOD CELL SEDIMENTATION RATE INCREASED |
6 |
0.0005 |
| 102 |
FOOT DEFORMITY |
6 |
0.0005 |
| 103 |
DYSURIA |
19 |
0.0005 |
| 104 |
HYPERAEMIA |
1 |
0.0005 |
| 105 |
ALLERGIC REACTION TO EXCIPIENT |
1 |
0.0005 |
| 106 |
CHANGE OF BOWEL HABIT |
1 |
0.0005 |
| 107 |
APPLICATION SITE EXFOLIATION |
2 |
0.0005 |
| 108 |
APPLICATION SITE SCAB |
1 |
0.0005 |
| 109 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 110 |
RHEUMATIC FEVER |
2 |
0.0004 |
| 111 |
FOREIGN BODY IN REPRODUCTIVE TRACT |
4 |
0.0004 |
| 112 |
TYPE 2 DIABETES MELLITUS |
15 |
0.0004 |
| 113 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 114 |
DYSPAREUNIA |
2 |
0.0004 |
| 115 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR |
1 |
0.0004 |
| 116 |
LYMPHADENITIS |
1 |
0.0004 |
| 117 |
C-REACTIVE PROTEIN INCREASED |
15 |
0.0004 |
| 118 |
PRODUCT ADMINISTRATION ERROR |
8 |
0.0004 |
| 119 |
CHEMICAL BURN OF SKIN |
1 |
0.0004 |
| 120 |
URINE OUTPUT INCREASED |
1 |
0.0004 |
| 121 |
OSTEOARTHRITIS |
15 |
0.0004 |
| 122 |
RHEUMATOID FACTOR POSITIVE |
2 |
0.0003 |
| 123 |
AUTONOMIC NERVOUS SYSTEM IMBALANCE |
1 |
0.0003 |
| 124 |
DRUG INEFFECTIVE |
441 |
0.0003 |
| 125 |
BLOOD CHOLESTEROL INCREASED |
15 |
0.0003 |
| 126 |
HEPATIC CIRRHOSIS |
6 |
0.0003 |
| 127 |
APPLICATION SITE PAIN |
7 |
0.0003 |
| 128 |
PRESCRIBED OVERDOSE |
6 |
0.0003 |
| 129 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
22 |
0.0003 |
| 130 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 131 |
WALKING AID USER |
2 |
0.0003 |
| 132 |
HYPERSENSITIVITY |
53 |
0.0003 |
| 133 |
NECROTISING FASCIITIS |
1 |
0.0003 |
| 134 |
ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE |
2 |
0.0003 |
| 135 |
AMYLASE INCREASED |
1 |
0.0003 |
| 136 |
DUODENAL ULCER PERFORATION |
2 |
0.0003 |
| 137 |
DEVICE FAILURE |
4 |
0.0003 |
| 138 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 139 |
EXPOSURE VIA BREAST MILK |
1 |
0.0003 |
| 140 |
OBSTRUCTION |
1 |
0.0003 |
| 141 |
DRUG EFFECT INCOMPLETE |
9 |
0.0002 |
| 142 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 143 |
INFUSION RELATED REACTION |
16 |
0.0002 |
| 144 |
MUSCLE INJURY |
2 |
0.0002 |
| 145 |
JOINT STIFFNESS |
6 |
0.0002 |
| 146 |
GRIP STRENGTH DECREASED |
2 |
0.0002 |
| 147 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 148 |
EAR INFECTION |
6 |
0.0002 |
| 149 |
HEPATIC ENZYME INCREASED |
15 |
0.0002 |
| 150 |
BREAST CANCER STAGE I |
2 |
0.0002 |
| 151 |
ROSACEA |
1 |
0.0002 |
| 152 |
SWELLING |
20 |
0.0002 |
| 153 |
MOBILITY DECREASED |
15 |
0.0002 |
| 154 |
AUTOIMMUNE DISORDER |
2 |
0.0002 |
| 155 |
APPLICATION SITE BURN |
1 |
0.0002 |
| 156 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 157 |
PHLEBITIS |
1 |
0.0002 |
| 158 |
INTENTIONAL PRODUCT USE ISSUE |
17 |
0.0002 |
| 159 |
TENDERNESS |
2 |
0.0002 |
| 160 |
FOLLICULITIS |
2 |
0.0002 |
| 161 |
ANORECTAL DISCOMFORT |
1 |
0.0002 |
| 162 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 163 |
WOUND INFECTION |
2 |
0.0002 |
| 164 |
ABORTION SPONTANEOUS |
7 |
0.0002 |
| 165 |
FEELING OF BODY TEMPERATURE CHANGE |
1 |
0.0002 |
| 166 |
ADVERSE DRUG REACTION |
15 |
0.0002 |
| 167 |
PEMPHIGUS |
2 |
0.0002 |
| 168 |
DERMATITIS ALLERGIC |
2 |
0.0002 |
| 169 |
DRUG INTOLERANCE |
15 |
0.0002 |
| 170 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 171 |
HAND DEFORMITY |
2 |
0.0002 |
| 172 |
JOINT RANGE OF MOTION DECREASED |
2 |
0.0001 |
| 173 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 174 |
OSTEOPOROSIS |
6 |
0.0001 |
| 175 |
APPLICATION SITE RASH |
2 |
0.0001 |
| 176 |
APPLICATION SITE REACTION |
1 |
0.0001 |
| 177 |
LIVER FUNCTION TEST INCREASED |
3 |
0.0001 |
| 178 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 179 |
BREAST TENDERNESS |
1 |
0.0001 |
| 180 |
HIP ARTHROPLASTY |
2 |
0.0001 |
| 181 |
MATERNAL DRUGS AFFECTING FOETUS |
1 |
0.0001 |
| 182 |
GENERAL PHYSICAL HEALTH DETERIORATION |
15 |
0.0001 |
| 183 |
CONGENITAL ANOMALY |
1 |
0.0001 |
| 184 |
CONCUSSION |
1 |
0.0001 |
| 185 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 186 |
SCIATICA |
2 |
0.0001 |
| 187 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 188 |
LIVER INJURY |
3 |
0.0001 |
| 189 |
ABNORMAL FAECES |
1 |
0.0001 |
| 190 |
HYPERAESTHESIA |
1 |
0.0001 |
| 191 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 192 |
FUNGAL INFECTION |
4 |
0.0001 |
| 193 |
PERICARDITIS |
2 |
0.0001 |
| 194 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 195 |
APPLICATION SITE ERYTHEMA |
3 |
0.0001 |
| 196 |
NAIL DISORDER |
1 |
0.0001 |
| 197 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 198 |
WRONG DRUG ADMINISTERED |
1 |
0.0001 |
| 199 |
SYNOVITIS |
2 |
0.0001 |
| 200 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
2 |
0.0001 |
| 201 |
PRODUCT DISTRIBUTION ISSUE |
1 |
0.0001 |
| 202 |
WOUND |
3 |
0.0001 |
| 203 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 204 |
PULMONARY FIBROSIS |
2 |
0.0001 |
| 205 |
LOWER LIMB FRACTURE |
2 |
0.0001 |
| 206 |
AFFECT LABILITY |
1 |
0.0001 |
| 207 |
SKIN FISSURES |
2 |
0.0001 |
| 208 |
ABDOMINAL DISCOMFORT |
17 |
0.0001 |
| 209 |
DISABILITY |
2 |
0.0001 |
| 210 |
MATERNAL EXPOSURE DURING PREGNANCY |
9 |
0.0001 |
| 211 |
HYPOAESTHESIA |
15 |
0.0001 |
| 212 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 213 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 214 |
KNEE ARTHROPLASTY |
2 |
0.0001 |
| 215 |
BREAST PAIN |
1 |
0.0001 |
| 216 |
BODY HEIGHT DECREASED |
1 |
0.0001 |
| 217 |
IRRITABLE BOWEL SYNDROME |
2 |
0.0001 |
| 218 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 219 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
2 |
0.0001 |
| 220 |
SKIN LACERATION |
1 |
0.0001 |
| 221 |
SKIN DISORDER |
3 |
0.0001 |
| 222 |
GAIT INABILITY |
3 |
0.0001 |
| 223 |
GLOSSODYNIA |
2 |
0.0001 |
| 224 |
BLISTER |
5 |
0.0001 |
| 225 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 226 |
EYE INFECTION |
1 |
0.0001 |
| 227 |
DRUG EXPOSURE DURING PREGNANCY |
3 |
0.0001 |
| 228 |
MICTURITION URGENCY |
1 |
0.0001 |
| 229 |
ADVERSE EVENT |
8 |
0.0001 |
| 230 |
UPPER RESPIRATORY TRACT INFECTION |
4 |
0.0001 |
| 231 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
6 |
0.0001 |
| 232 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
17 |
0.0001 |
| 233 |
URTICARIA |
14 |
0.0001 |
| 234 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 235 |
EYE SWELLING |
3 |
0.0001 |
| 236 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 237 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 238 |
RASH GENERALISED |
2 |
0.0001 |
| 239 |
PLATELET COUNT INCREASED |
1 |
0.0001 |
| 240 |
NODULE |
1 |
0.0001 |
| 241 |
ALOPECIA |
15 |
0.0001 |
| 242 |
ARTHRITIS |
6 |
0.0001 |
| 243 |
ADVERSE REACTION |
1 |
0.0001 |
| 244 |
EXTRA DOSE ADMINISTERED |
3 |
0.0001 |
| 245 |
DECREASED APPETITE |
17 |
0.0001 |
| 246 |
ABDOMINAL PAIN |
17 |
0.0001 |
| 247 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
13 |
0.0001 |
| 248 |
BURNING SENSATION |
5 |
0.0001 |
| 249 |
SKIN REACTION |
1 |
0.0001 |
| 250 |
HYPERTENSION |
15 |
0.0001 |
| 251 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 252 |
PRODUCT USE IN UNAPPROVED INDICATION |
17 |
0.0001 |
| 253 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0001 |
| 254 |
DRUG ADMINISTRATION ERROR |
2 |
0.0001 |
| 255 |
EXPOSURE DURING PREGNANCY |
4 |
0.0001 |
| 256 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 257 |
IMPAIRED HEALING |
2 |
0.0001 |
| 258 |
CHILLS |
7 |
0.0001 |
| 259 |
FACE OEDEMA |
1 |
0.0001 |
| 260 |
METRORRHAGIA |
1 |
0.0001 |
| 261 |
ABDOMINAL PAIN UPPER |
12 |
0.0001 |
| 262 |
DELIRIUM |
2 |
0.0001 |
| 263 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 264 |
SLEEP DISORDER |
4 |
0.0001 |
| 265 |
VISUAL IMPAIRMENT |
7 |
0.0001 |
| 266 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 267 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
2 |
0.0001 |
| 268 |
PELVIC PAIN |
1 |
0.0001 |
| 269 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 270 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 271 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 272 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 273 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 274 |
HAEMORRHOIDS |
1 |
0.0001 |
| 275 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 276 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 277 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 278 |
PSORIATIC ARTHROPATHY |
2 |
0.0000 |
| 279 |
OEDEMA PERIPHERAL |
6 |
0.0000 |
| 280 |
DISCOMFORT |
3 |
0.0000 |
| 281 |
POLLAKIURIA |
2 |
0.0000 |
| 282 |
ROAD TRAFFIC ACCIDENT |
2 |
0.0000 |
| 283 |
EATING DISORDER |
1 |
0.0000 |
| 284 |
IMPAIRED WORK ABILITY |
1 |
0.0000 |
| 285 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 286 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 287 |
AMNESIA |
3 |
0.0000 |
| 288 |
INTENTIONAL PRODUCT MISUSE |
4 |
0.0000 |
| 289 |
FEBRILE NEUTROPENIA |
3 |
0.0000 |
| 290 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 291 |
CHROMATURIA |
1 |
0.0000 |
| 292 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 293 |
SHOCK |
1 |
0.0000 |
| 294 |
ARTHRALGIA |
18 |
0.0000 |
| 295 |
CHEST PAIN |
8 |
0.0000 |
| 296 |
INJURY |
3 |
0.0000 |
| 297 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 298 |
PRESYNCOPE |
1 |
0.0000 |
| 299 |
OFF LABEL USE |
36 |
0.0000 |
| 300 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 301 |
OSTEONECROSIS OF JAW |
1 |
0.0000 |
| 302 |
ABDOMINAL PAIN LOWER |
1 |
0.0000 |
| 303 |
PRODUCT COMPLAINT |
1 |
0.0000 |
| 304 |
INFLAMMATION |
2 |
0.0000 |
| 305 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 306 |
VOMITING |
18 |
0.0000 |
| 307 |
HEADACHE |
24 |
0.0000 |
| 308 |
DIZZINESS |
19 |
0.0000 |
| 309 |
DRUG EFFECT DECREASED |
2 |
0.0000 |
| 310 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 311 |
OEDEMA |
2 |
0.0000 |
| 312 |
LIMB INJURY |
1 |
0.0000 |
| 313 |
ARTHROPATHY |
2 |
0.0000 |
| 314 |
SKIN EXFOLIATION |
3 |
0.0000 |
| 315 |
FLATULENCE |
2 |
0.0000 |
| 316 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 317 |
MUSCULOSKELETAL STIFFNESS |
3 |
0.0000 |
| 318 |
WHEEZING |
2 |
0.0000 |
| 319 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 320 |
FEELING HOT |
2 |
0.0000 |
| 321 |
RASH |
14 |
0.0000 |
| 322 |
VIRAL INFECTION |
1 |
0.0000 |
| 323 |
LIP SWELLING |
1 |
0.0000 |
| 324 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 325 |
PAIN |
18 |
0.0000 |
| 326 |
SINUSITIS |
3 |
0.0000 |
| 327 |
ACCIDENTAL EXPOSURE TO PRODUCT |
3 |
0.0000 |
| 328 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 329 |
RASH MACULAR |
1 |
0.0000 |
| 330 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 331 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 332 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
1 |
0.0000 |
| 333 |
CRYING |
1 |
0.0000 |
| 334 |
PANIC ATTACK |
1 |
0.0000 |
| 335 |
BRONCHITIS |
2 |
0.0000 |
| 336 |
DYSGEUSIA |
2 |
0.0000 |
| 337 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 338 |
NAUSEA |
20 |
0.0000 |
| 339 |
JOINT SWELLING |
3 |
0.0000 |
| 340 |
PNEUMONIA |
8 |
0.0000 |
| 341 |
FATIGUE |
19 |
0.0000 |
| 342 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 343 |
PAIN IN EXTREMITY |
7 |
0.0000 |
| 344 |
PRURITUS |
9 |
0.0000 |
| 345 |
SEPTIC SHOCK |
1 |
0.0000 |
| 346 |
INSOMNIA |
6 |
0.0000 |
| 347 |
TACHYCARDIA |
2 |
0.0000 |
| 348 |
THROAT IRRITATION |
1 |
0.0000 |
| 349 |
SKIN IRRITATION |
1 |
0.0000 |
| 350 |
HYPOKALAEMIA |
1 |
0.0000 |
| 351 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 352 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 353 |
DYSPHAGIA |
2 |
0.0000 |
| 354 |
MIGRAINE |
2 |
0.0000 |
| 355 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 356 |
CONTUSION |
2 |
0.0000 |
| 357 |
SYNCOPE |
2 |
0.0000 |
| 358 |
CELLULITIS |
1 |
0.0000 |
| 359 |
THERAPY CESSATION |
1 |
0.0000 |
| 360 |
PERIPHERAL SWELLING |
3 |
0.0000 |
| 361 |
PANCREATITIS |
1 |
0.0000 |
| 362 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 363 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 364 |
HYPONATRAEMIA |
1 |
0.0000 |
| 365 |
ASTHMA |
2 |
0.0000 |
| 366 |
RHEUMATOID ARTHRITIS |
2 |
0.0000 |
| 367 |
MUSCULAR WEAKNESS |
2 |
0.0000 |
| 368 |
ANXIETY |
5 |
0.0000 |
| 369 |
LETHARGY |
1 |
0.0000 |
| 370 |
EYE IRRITATION |
1 |
0.0000 |
| 371 |
PRODUCT SUBSTITUTION ISSUE |
1 |
0.0000 |
| 372 |
PYREXIA |
6 |
0.0000 |
| 373 |
PALPITATIONS |
2 |
0.0000 |
| 374 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 375 |
MUSCLE SPASMS |
3 |
0.0000 |
| 376 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 377 |
MALAISE |
7 |
0.0000 |
| 378 |
HYPERHIDROSIS |
2 |
0.0000 |
| 379 |
PSORIASIS |
2 |
0.0000 |
| 380 |
INJECTION SITE PRURITUS |
1 |
0.0000 |
| 381 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 382 |
WEIGHT DECREASED |
4 |
0.0000 |
| 383 |
INFECTION |
2 |
0.0000 |
| 384 |
CONSTIPATION |
3 |
0.0000 |
| 385 |
WEIGHT INCREASED |
3 |
0.0000 |
| 386 |
ACNE |
1 |
0.0000 |
| 387 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 388 |
BACK PAIN |
3 |
0.0000 |
| 389 |
DRUG INTERACTION |
2 |
0.0000 |
| 390 |
THROMBOSIS |
1 |
0.0000 |
| 391 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 392 |
DYSPNOEA |
7 |
0.0000 |
| 393 |
DRY MOUTH |
1 |
0.0000 |
| 394 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 395 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 396 |
COVID-19 |
2 |
0.0000 |
| 397 |
NASOPHARYNGITIS |
2 |
0.0000 |
| 398 |
DYSPEPSIA |
1 |
0.0000 |
| 399 |
ILLNESS |
1 |
0.0000 |
| 400 |
DEPRESSION |
2 |
0.0000 |
| 401 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 402 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 403 |
DIARRHOEA |
5 |
0.0000 |
| 404 |
RENAL FAILURE |
1 |
0.0000 |
| 405 |
DRY SKIN |
1 |
0.0000 |
| 406 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 407 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 408 |
BLOOD PRESSURE INCREASED |
1 |
0.0000 |
| 409 |
HOSPITALISATION |
1 |
0.0000 |
| 410 |
PARAESTHESIA |
1 |
0.0000 |
| 411 |
DRUG DEPENDENCE |
1 |
0.0000 |
| 412 |
TREMOR |
1 |
0.0000 |
| 413 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 414 |
MYALGIA |
1 |
0.0000 |
| 415 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 416 |
PRODUCT USE ISSUE |
1 |
0.0000 |
| 417 |
ASTHENIA |
2 |
0.0000 |
| 418 |
ANAEMIA |
1 |
0.0000 |
| 419 |
SOMNOLENCE |
1 |
0.0000 |
| 420 |
ERYTHEMA |
1 |
0.0000 |
| 421 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 422 |
FEELING ABNORMAL |
1 |
0.0000 |
| 423 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 424 |
FALL |
1 |
0.0000 |
| 425 |
DEATH |
2 |
0.0000 |